Oct. 23 at 1:25 PM
Noble Capital Markets Research Report: Nutriband (
$NTRB) – Highlights From Noble’s Virtual Conference
Nutriband Is Developing Transdermal Abuse-Deterrent Technologies. Nutriband has developed abuse-deterrent technology for dermal patch drug delivery. Serguei Melnik, Interim CEO, and Irina Gram, Director, highlighted the company’s platform, known as AVERSA, and its focus on patches containing FDA-approved drugs. The presentation may be viewed here.
Read more: https://www.channelchek.com/news-channel/nutriband-ntrb-highlights-from-nobles-virtual-conference